Here we determined the functional consequences of other MLK1 mutations from melanoma patients that were identified by Stark et al.8 We observed that several of these mutations (including recurrent mutations) were gain-of-function (GOF) towards the MEK/ERK pathway when compared with WT MLK1 (Fig. 6b). Here, MAP3K9 is linked to melanoma.